Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypertension

Free Subscription Articles published in Circulation Retrieve available abstracts of 104 articles: HTML format

Single Articles

September 2026
1. ZHANG J, Li Y, He M, Tan J, et al
   PUS7-Mediated Pseudouridylation of TGFBI Drives Vascular Remodeling in Pulmonary Hypertension.
   Circulation. 2026 Sep 1. doi: 10.1161/CIRCULATIONAHA.126.080714.
   PubMed     Abstract available
   
   
   
2. LYNCH PT, Makkapati S, George JC, Vaidya A, et al
   Left Circumflex Coronary-Pulmonary Arterial Collaterals in Chronic Thromboembolic Pulmonary Hypertension.
   Circulation. 2026;154:872.
   PubMed    
   
   
   
3. LOH KWZ, Zhou Y, Liu C, Zhai J, et al
   Galectin-3 Regulates Smooth Muscle Contraction and Blood Pressure by Modulating Ca(V)1.2 Channel Function.
   Circulation. 2026;154:819-834.
   PubMed     Abstract available
   
   
   August 2026
4. POST WS
   Hypertension Control Programs: A Global Call to Action.
   Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.083073.
   PubMed    
   
   
   
5. CHEN Z, Zhang H, Yang Q, Fan L, et al
   METTL7B Mitigates Hypertension and Vascular Remodeling.
   Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.126.079407.
   PubMed     Abstract available
   
   
   
6. GRIFFITHS M, Chinni BK, Lokhorst C, Douwes JM, et al
   The Pediatric Pulmonary Hypertension International Risk Score: A Prediction Model for Outcomes Using Machine Learning.
   Circulation. 2026 Aug 11. doi: 10.1161/CIRCULATIONAHA.125.077391.
   PubMed     Abstract available
   
   
   
7. HU M, Liu L, Zhou W
   Letter by Hu et al Regarding Article, "Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage".
   Circulation. 2026;154:e235-e236.
   PubMed    
   
   
   
8. POUDEL B, Susztak K
   Response by Poudel and Susztak to Letter Regarding Article, "Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage".
   Circulation. 2026;154:e237-e238.
   PubMed    
   
   
   
9. WANG L, Staps M, Gunther S, El Agha E, et al
   Cell Type-Specific Targeting of Different Smooth Muscle Cell Populations by Intersectional Genetics.
   Circulation. 2026;154:565-583.
   PubMed     Abstract available
   
   
   July 2026
10. HUMBERT M, Zeder K, Kovacs G, Weatherald J, et al
    Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.
    Circulation. 2026;154:156-177.
    PubMed     Abstract available
    
    
    June 2026
11. NGUYEN M, AlEssa HB, Glenn AJ, Tobias DK, et al
    Consumption of Fructose-Containing Food and Beverage Sources in Childhood Through to Adulthood and Risk of Hypertension: A Prospective Cohort Study.
    Circulation. 2026 Jun 22:10.1161/CIRCULATIONAHA.125.077666.
    PubMed     Abstract available
    
    
    
12. ALKHODARI M, Lapidaire W, Kart T, Xiong Z, et al
    Contrastive Machine Learning to Quantify Hypertensive Multiorgan Damage and Identify New Disease Phenotypes: A Multinational Multimodal Study.
    Circulation. 2026 Jun 21. doi: 10.1161/CIRCULATIONAHA.125.077394.
    PubMed     Abstract available
    
    
    
13. WANG Q, Tian J, Liu D, Zheng T, et al
    Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
    Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.066183.
    PubMed     Abstract available
    
    
    May 2026
14. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026;153:e1362.
    PubMed    
    
    
    
15. HOU Y, Li Q, Wei TW, Lin X, et al
    Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
    Circulation. 2026 May 26. doi: 10.1161/CIRCULATIONAHA.124.073606.
    PubMed     Abstract available
    
    
    
16. SARMA S, Chin KM
    Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:1460-1462.
    PubMed    
    
    
    
17. LI R, Tang Y, Ding Y, Hu P, et al
    GPRASP1 Safeguards Endothelial Aspartate Metabolism to Prevent Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026 May 7. doi: 10.1161/CIRCULATIONAHA.126.079030.
    PubMed     Abstract available
    
    
    April 2026
18. FARMER N, Wei Y, Albin JL
    Culinary Medicine as a Key Lever in Hypertension Management.
    Circulation. 2026;153:1083-1085.
    PubMed    
    
    
    
19. SARFO FS, Akpalu A, Bockarie AS, Nguah SB, et al
    Phone-Based Intervention Under Nurse Guidance for Control of Hypertension After Stroke: A Randomized Multicenter Phase 3 Trial in Ghana.
    Circulation. 2026 Apr 9. doi: 10.1161/CIRCULATIONAHA.125.077424.
    PubMed     Abstract available
    
    
    
20. PULLAMSETTI SS, Vanderpool RR, de Man F, de Jesus Perez VA, et al
    Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Apr 2. doi: 10.1161/CIR.0000000000001422.
    PubMed     Abstract available
    
    
    March 2026
21. GARRY JD, Brittain EL
    Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data.
    Circulation. 2026;153:980-982.
    PubMed    
    
    
    
22. FORBES LM, Cornwell WK
    Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype.
    Circulation. 2026;153:963-966.
    PubMed    
    
    
    
23. GOMBERG-MAITLAND M, Tedford RJ, Langleben D, Rosenkranz S, et al
    Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
    Circulation. 2026 Mar 29. doi: 10.1161/CIRCULATIONAHA.126.079918.
    PubMed     Abstract available
    
    
    
24. ZHANG Y, Bonnet S, Provencher S, Piao J, et al
    A Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078674.
    PubMed     Abstract available
    
    
    February 2026
25. SHOREY-KENDRICK LE, Ladd-Acosta C, Zhao H, Aschner JL, et al
    Association of Maternal Smoking During Pregnancy With Childhood Blood Pressure and Hypertension in the ECHO Cohort.
    Circulation. 2026;153:536-539.
    PubMed    
    
    
    
26. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    PubMed     Abstract available
    
    
    
27. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
    Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
    PubMed     Abstract available
    
    
    
28. JAMBON-BARBARA C, Suissa S, Dell'Aniello S, Hlavaty A, et al
    Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.077764.
    PubMed     Abstract available
    
    
    January 2026
29. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
    PubMed     Abstract available
    
    
    
30. TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
    Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
    Circulation. 2026;153:285-289.
    PubMed    
    
    
    
31. COHEN JB, Jones DW, Flack JM
    From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change.
    Circulation. 2026;153:137-139.
    PubMed    
    
    
    December 2025
32. LI F, Poudel B, Andrade-Silva M, Wu J, et al
    Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.
    Circulation. 2025 Dec 11:10.1161/CIRCULATIONAHA.124.071351.
    PubMed     Abstract available
    
    
    October 2025
33. CAI A, Bayes-Genis A, Ryan J, Feng Y, et al
    Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
    Circulation. 2025 Oct 22. doi: 10.1161/CIRCULATIONAHA.125.076263.
    PubMed     Abstract available
    
    
    
34. LIU J, Zhang L, Chen Z
    Letter by Liu et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e285-e286.
    PubMed    
    
    
    
35. HUANG J
    Letter by Huang Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e289-e290.
    PubMed    
    
    
    
36. JOHNSTON A, Edwards JD, Coutinho T
    Response by Johnston et al to Letters Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e291-e292.
    PubMed    
    
    
    
37. FAUCHIER L, Lochon L, Lip GYH
    Letter by Fauchier et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e287-e288.
    PubMed    
    
    
    
38. KORNELIUS E
    Letter by Kornelius Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e284.
    PubMed    
    
    
    September 2025
39. JONES DW, Ferdinand KC, Taler SJ, Johnson HM, et al
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Commit
    Circulation. 2025;152:e114-e218.
    PubMed     Abstract available
    
    
    August 2025
40. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    PubMed     Abstract available
    
    
    June 2025
41. ZHANG F, Zhong Y
    Letter by Zhang and Zhong Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1072.
    PubMed    
    
    
    
42. VUKADINOVIC D, Lauder L, Mahfoud F
    Response by Vukadinovic et al to Letter Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1073-e1074.
    PubMed    
    
    
    
43. WANG J, Yuan Z, Yu N, Jiao Q, et al
    Inactivation of RhoA for Hypertension Treatment Through the TRPV4-RhoA-RhoGDI1 Axis.
    Circulation. 2025 Jun 16. doi: 10.1161/CIRCULATIONAHA.124.071884.
    PubMed     Abstract available
    
    
    
44. KIM HK, Fukazawa A, Smith SA, Mizuno M, et al
    High Dietary Phosphate Intake Induces Hypertension and Sympathetic Overactivation Through Central Fibroblast Growth Factor Receptor Signaling.
    Circulation. 2025 Jun 5. doi: 10.1161/CIRCULATIONAHA.124.071605.
    PubMed     Abstract available
    
    
    April 2025
45. YU Q, Tai YY, Tang Y, Zhao J, et al
    Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2025;151:e967.
    PubMed    
    
    
    
46. AGRAWAL V, Hemnes AR
    Integrin Targeting Therapies in Pulmonary Arterial Hypertension: A Roadmap for Traversing the Translational Valley of Death?
    Circulation. 2025;151:1184-1186.
    PubMed    
    
    
    
47. SINGH R, Kulthinee S, Nasci VL, Akwo EA, et al
    G-Protein-Coupled Estrogen Receptor 1 and Pregnancy Confer Protection Against Hypertension in Older Females.
    Circulation. 2025;151:1126-1129.
    PubMed    
    
    
    
48. HONG J, Medzikovic L, Sun W, Wong B, et al
    Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2025;151:e921.
    PubMed    
    
    
    
49. CAO N, Lan C, Chen C, Xu Z, et al
    Correction to: Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2025;151:e866.
    PubMed    
    
    
    March 2025
50. NIIRANEN TJ, Schnabel RB, Schutte AE, Biton Y, et al
    Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration.
    Circulation. 2025;151:863-877.
    PubMed     Abstract available
    
    
    
51. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2025;151:e763.
    PubMed    
    
    
    
52. VONGPATANASIN W, Turcu AF
    The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to American Heart Association/American College of Cardiology Guidelines.
    Circulation. 2025;151:653-655.
    PubMed    
    
    
    
53. DAI H, Lu X, Zhou X
    Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
    Circulation. 2025;151:e686.
    PubMed    
    
    
    February 2025
54. YU AYX, Auger N, Fu L, Chu A, et al
    Population-Level Screening for Diabetes and Dyslipidemia After Pregnancies Complicated by Hypertension or Diabetes.
    Circulation. 2025;151:508-510.
    PubMed    
    
    
    
55. COUNTOURIS M, Mahmoud Z, Cohen JB, Crousillat D, et al
    Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care.
    Circulation. 2025;151:490-507.
    PubMed     Abstract available
    
    
    
56. JOHNSTON A, Petrcich W, Smith GN, Fell DB, et al
    Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study.
    Circulation. 2025 Feb 11. doi: 10.1161/CIRCULATIONAHA.124.072418.
    PubMed     Abstract available
    
    
    
57. KRESS TC, Barris CT, Kovacs L, Khakina BN, et al
    CD4(+) T Cells Expressing Viral Proteins Induce HIV-Associated Endothelial Dysfunction and Hypertension Through Interleukin 1alpha-Mediated Increases in Endothelial NADPH Oxidase 1.
    Circulation. 2025 Feb 5. doi: 10.1161/CIRCULATIONAHA.124.070538.
    PubMed     Abstract available
    
    
    January 2025
58. HOEPER MM, Haughie S, Hassan T, Vogt S, et al
    Response by Hoeper et al to Letter Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults with Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e32.
    PubMed    
    
    
    
59. YAN P, Zhang M, Cao Y
    Letter by Yan et al Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e31.
    PubMed    
    
    
    
60. LEMAY SE, Montesinos MS, Grobs Y, Yokokawa T, et al
    Exploring Integrin alpha5beta1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
    Circulation. 2025 Jan 20. doi: 10.1161/CIRCULATIONAHA.124.070693.
    PubMed     Abstract available
    
    
    December 2024
61. LAFFIN LJ
    Future of Antihypertensive Therapies.
    Circulation. 2024;150:1987-1989.
    PubMed    
    
    
    November 2024
62. ZHANG M, Pan X, Zhu X
    Letter by Zhang et al Regarding Article, "Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era".
    Circulation. 2024;150:e467.
    PubMed    
    
    
    
63. MCLAUGHLIN VV, Humbert M
    Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.
    Circulation. 2024;150:1653-1655.
    PubMed    
    
    
    October 2024
64. BARONE GIBBS B, Perera S, Huber KA, Paley JL, et al
    Effects of Sedentary Behavior Reduction on Blood Pressure in Desk Workers: Results From the RESET-BP Randomized Clinical Trial.
    Circulation. 2024;150:1416-1427.
    PubMed     Abstract available
    
    
    
65. DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
    Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
    Circulation. 2024;150:1354-1365.
    PubMed     Abstract available
    
    
    
66. VUKADINOVIC D, Lauder L, Kandzari DE, Bhatt DL, et al
    Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Oct 2. doi: 10.1161/CIRCULATIONAHA.124.069709.
    PubMed     Abstract available
    
    
    
67. GIANNOPOULOS AA, Gimelli A
    Unveiling the Hidden Layers of Hypertensive Heart Disease Through Quantitative PET Imaging.
    Circulation. 2024;150:1087-1089.
    PubMed    
    
    
    September 2024
68. JIANG X, Mahfoud F, Li W, Dong H, et al
    Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069215.
    PubMed     Abstract available
    
    
    August 2024
69. HONG J, Medzikovic L, Sun W, Wong B, et al
    Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069864.
    PubMed     Abstract available
    
    
    
70. XU X, Divakaran S, Weber BN, Hainer J, et al
    Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.067083.
    PubMed     Abstract available
    
    
    
71. ZHANG Z, Liu K, Chen X
    Letter by Zhang et al Regarding Article, "Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program".
    Circulation. 2024;150:e181-e182.
    PubMed    
    
    
    July 2024
72. LIU B, Yi D, Xia X, Ramirez K, et al
    General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2alpha/Notch4 Pathway.
    Circulation. 2024;150:414-417.
    PubMed    
    
    
    
73. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial.
    Circulation. 2024;150:230-242.
    PubMed     Abstract available
    
    
    June 2024
74. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
    PubMed     Abstract available
    
    
    
75. ZHANG Q, Yaoita N, Tabuchi A, Liu S, et al
    Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.124.068726.
    PubMed     Abstract available
    
    
    
76. 
    Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1412.
    PubMed    
    
    
    May 2024
77. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.
    PubMed    
    
    
    
78. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    PubMed     Abstract available
    
    
    
79. HOEPER MM, Ewert R, Jansa P, Sirenko Y, et al
    Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107.
    PubMed     Abstract available
    
    
    
80. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    PubMed    
    
    
    
81. HARING B, Andrews CA, Hovey K, Shadyab AH, et al
    Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative.
    Circulation. 2024;149:1568-1577.
    PubMed     Abstract available
    
    
    
82. TANG H, Gupta A, Morrisroe SA, Bao C, et al
    Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
    Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
    PubMed     Abstract available
    
    
    April 2024
83. BORDAN Z, Batori R, Haigh S, Li X, et al
    PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
    PubMed     Abstract available
    
    
    
84. RAO RJ, Chan SY
    Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
    Circulation. 2024;149:1372-1374.
    PubMed    
    
    
    
85. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    PubMed     Abstract available
    
    
    
86. KANDZARI DE, Weber MA, Pathak A, Zidar JP, et al
    Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.
    Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.124.069291.
    PubMed     Abstract available
    
    
    
87. SHEN H, Gao Y, Ge D, Tan M, et al
    BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
    PubMed     Abstract available
    
    
    March 2024
88. PETER JG, Ntusi NAB, Ntsekhe M
    Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?
    Circulation. 2024;149:804-806.
    PubMed    
    
    
    
89. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    PubMed     Abstract available
    
    
    February 2024
90. REDING KW, Jordan JH
    Multimodal Imaging Evidence for Optimized Blood Pressure Control Following Hypertensive Pregnancy: Mechanistic Insights Into Beneficial Cardiac Remodeling From the POP-HT Trial.
    Circulation. 2024;149:542-544.
    PubMed    
    
    
    
91. PITT B, Williams GH
    Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
    Circulation. 2024;149:414-416.
    PubMed    
    
    
    
92. LUO Y, Qi X, Zhang Z, Zhang J, et al
    Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
    Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
    PubMed     Abstract available
    
    
    January 2024
93. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    PubMed     Abstract available
    
    
    December 2023
94. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed     Abstract available
    
    
    
95. REAY WR, Clarke E, Eslick S, Riveros C, et al
    Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
    Circulation. 2023 Dec 22. doi: 10.1161/CIRCULATIONAHA.123.065394.
    PubMed     Abstract available
    
    
    
96. RASMUSSEN SB, Jeppesen KK, Kjaergaard J, Hassager C, et al
    Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest.
    Circulation. 2023;148:1860-1869.
    PubMed     Abstract available
    
    
    November 2023
97. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    PubMed     Abstract available
    
    
    
98. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    PubMed    
    
    
    
99. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    PubMed    
    
    
    
100. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
     A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
     Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
     PubMed    
     
     
     
101. KITT J, Krasner S, Barr L, Frost A, et al
     Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
     Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
     PubMed     Abstract available
     
     
     October 2023
102. AZIZI M, Sharp ASP, Fisher NDL, Weber MA, et al
     Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program.
     Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.066941.
     PubMed     Abstract available
     
     
     
103. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
     Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
     Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
     PubMed     Abstract available
     
     
     September 2023
104. KUEHN BM
     Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
     Circulation. 2023;148:852-854.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum